Nucleic acids encoding antiviral proteins and peptides fused to effector proteins
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsMichael R. Boyd, Robert H. Shoemaker
Life of this patent
Estimating the term…
Abstract
The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences encoding such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.
Claims4
An isolated and purified nucleic acid molecule comprising a first nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding at least nine contiguous amino acids of SEQ ID NO:2, a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:4, a nucleic acid sequence comprising the sequence of SEQ ID NO:1, a nucleic acid sequence comprising the sequence of SEQ ID NO:3 coupled to a second nucleic acid sequence encoding an effector protein, wherein said first nucleic acid sequence encodes a peptide or protein having antiviral activity.
An isolated and purified nucleic acid molecule comprising a first nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:2 coupled to a second nucleic acid sequence encoding an effector protein.
Dependencies are inferred from the claim text.